EUROPEAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-12-29 rayms

为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？

78 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2022-02-15 ms1000000321963424

2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2020-12-29 12542404m56(暂无昵称)

投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！

172 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-12-29 小动量

每个期刊的格式要求一样么？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-10-30 ms5000002013297398

要求字数2500？怎么感觉发的文章都超过2500了？

80 0

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-10-05 YJJJJJ

9-23 submittted
9-26 with editor
9-29 decision in process
10-5 reject
和很多人说的一样，decision in process状态持续的很久。

74 0

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-08-19 平ing

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0
偏重的研究方向：SLE
经验分享：多写多投

74 0

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2020-12-03 独行er

审稿速度:1.0
偏重的研究方向：胃肠外科
经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊

139 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-03-06 mmz2101863

审稿速度:2.0
经验分享：2021-01-29提交
2021-02-01 with editor
2021-03-01 decision in process
中间没有 undrer review，网上询问网友的结果是多半悲剧。

102 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009536, encodeId=e2e110095369f, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2000.0 偏重的研究方向：SLE 经验分享：多写多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=073d5578676, createdName=平ing, createdTime=Thu Aug 19 20:27:05 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924083, encodeId=1399924083d9, content=大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Feb 10 16:43:01 CST 2021, time=2021-02-10, status=1, ipAttribution=)]

2021-02-10 a201061519

大神们，，，，这个期刊是不是只要临床实验？？投过的哥姐们分享下经验。感谢🙏

118 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务